Appistry Launches Integrated Suite for Cancer Genome Analysis

ST. LOUIS, Jul 24, 2013 (BUSINESS WIRE) -- Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, launched today an integrated suite of tools for analyzing next-generation sequencing (NGS) cancer genome data. In particular, the Cancer Genome Analysis Suite contains a tool engineered to provide the high sensitivity required for identifying low-frequency point mutations, hard-to-find discrepancies in DNA sequences that are a genetic hallmark of tumor development and evolution.

Read more at http://www.marketwatch.com/story/appistry-launches-integrated-suite-for-cancer-genome-analysis-2013-07-24